@Xtalks Avatar @Xtalks Xtalks Webinars

Xtalks Webinars posts on X about ipo, hosted, health, ceo the most. They currently have [------] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [------] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 31.5% finance 23.62% countries 4.72% exchanges 3.15% technology brands 2.36% cryptocurrencies 2.36% social networks 0.79% currencies 0.79%

Social topic influence ipo 14.96%, hosted #823, health 7.87%, ceo 7.09%, how to 6.3%, company 4.72%, the first 3.94%, ai 3.94%, future 3.94%, reduce #1381

Top accounts mentioned or mentioned by @soumya2390 @ayeshar1202 @verakovacevic3 @sarahhandmsc @bioclinica @cluepoints @oncodesignsa @syngeneintl @klothoneurosci @diamedica @atossainc @galderma @medtronicnv @augurex @marklogics @druginfoassn @synteract @syneoshealth @marklogic @omnicommsystems

Top assets mentioned Novartis AG (NVS) Vera Therapeutics, Inc. (VERA) Eli Lilly and Company (LLY) Alphabet Inc Class A (GOOGL) Medtronic PLC (MDT) Maze Therapeutics, Inc. (MAZE) Sionna Therapeutics, Inc. (SION) Aardvark Therapeutics, Inc (AARD) Coya Therapeutics, Inc. (COYA) Caris Life Sciences, Inc. (CAI) Shoulder Innovations, Inc. (SI) Johnson & Johnson (JNJ) CVS Health Corp (CVS)

Top Social Posts

Top posts by engagements in the last [--] hours

"Researchers at UT Southwestern Medical Center have stopped the progression of Duchenne muscular dystrophy in dogs using the #CRISPR #geneediting technique. This is the first time this technique has been successfully used in a large mammal. https://buff.ly/2MGo7zX https://buff.ly/2MGo7zX"
X Link 2018-09-20T01:30Z 26K followers, [--] engagements

"deCODE Genetics Unveils the Most High-Resolution Map of the #HumanGenome Two decades worth of work have cumulated into the first full-resolution map of the human genome giving scientists info about how genes are passed down multiple generations and more. https://buff.ly/2FP31ki https://buff.ly/2FP31ki"
X Link 2019-01-25T17:00Z 26K followers, [--] engagements

"MMR Vaccines Now Mandatory Amid New York #Measles Outbreak #Immunization https://buff.ly/2ZuK3Wn https://buff.ly/2ZuK3Wn"
X Link 2019-04-23T13:28Z 26K followers, [--] engagements

"Helllllllooooo San Diego The @Xtalks team has landed and are looking forward to an exciting couple of days covering #DIA2019 this Monday & Tuesday. Stay tuned for content coming your way #SanDiego"
X Link 2019-06-24T00:39Z 26K followers, [--] engagements

"Today is #ClinicalTrialsDay [----]. In a year marked by a global pandemic and massive changes in #clinicalresearch here is what five insiders are saying about the state of the industry. Read more by @AyeshaR1202 & @SarahHandMSc #CTD2021 #ICTD2021 #COVID19 https://buff.ly/3tZbea4 https://buff.ly/3tZbea4"
X Link 2021-05-20T16:30Z 26K followers, [--] engagements

"Healthcare layoffs continue into [----] as hospitals payers and healthcare services organizations adjust staffing amid funding and cost pressures. See the roundup at by @soumya2390. #HealthcareLayoffs #HealthcareWorkforce #Hospitals #HealthInsurance #Medicaid #HealthcareNews https://buff.ly/D9uaXZC https://buff.ly/D9uaXZC"
X Link 2026-02-12T18:36Z 26K followers, [--] engagements

"AstraZenecas $1.2B agreement with CSPC spans eight obesity and type [--] diabetes programs and includes AI-enabled peptide discovery and once-monthly dosing technology. Heres more on the AstraZeneca-CSPC Pharma deal by @soumya2390 at #AstraZeneca #Obesity #Type2Diabetes #GLP1 #DrugDevelopment #Biopharma https://buff.ly/KDuIAqC https://buff.ly/KDuIAqC"
X Link 2026-02-12T21:38Z 26K followers, [--] engagements

"Explore how organizations can achieve local compliance on a global scale with Jay Gandecha and Ana Pedro Jesuno in this strategic webinar hosted by IQVIA. They will discuss the benefits of integrating Local Qualified Person for Pharmacovigilance (LQPPV) responsibilities with comprehensive Lifecycle Management (LCM) to create unified governance and reduce operational duplication across the enterprise. Register now to discover how applied AI and adaptive resourcing models can allow sponsors to maintain high compliance standards across complex multi-country environments without being locked into"
X Link 2026-02-11T14:37Z 26K followers, [--] engagements

"Unlock high-value insights in early-phase oncology trials with Todd Rudo MD Anu Bansal MD MS Robert Kleiman MD and Kelly Dumais PhD in this webinar hosted by Clario. They will examine how advanced image analysis and concentration-effect modeling for cardiac safety are delivering deeper more sensitive data than traditional strategies. Register now to learn how integrating early patient-reported endpoints and pharmacokinetics can strengthen clinician assessments and support rapid evidence-based dose selection: #Clario #Oncology #EarlyPhase #ClinicalTrials #MedicalImaging #CardiacSafety #eCOA"
X Link 2026-02-12T14:37Z 26K followers, [--] engagements

"From R&D centers to manufacturing sites AstraZenecas $15B China investment details how the company plans to scale development and production through [----]. Heres a closer look at the AstraZeneca China investment at by @soumya2390 . #AstraZeneca #ChinaInvestment #DrugDevelopment #Biopharma #LifeSciences https://buff.ly/AsAhVKv https://buff.ly/AsAhVKv"
X Link 2026-02-13T14:56Z 26K followers, [--] engagements

"The FDA has cleared Optune Pax a portable device delivering tumor treating fields for use with chemotherapy in locally advanced pancreatic cancer. We break down how it works and what the Phase III data showed at by @soumya2390. #PancreaticCancer #MedicalDevices #FDAClearance #OncologyResearch https://buff.ly/UKgCxvB https://buff.ly/UKgCxvB"
X Link 2026-02-13T14:57Z 26K followers, [--] engagements

"The FDA has cleared Noise Reduction an AI-based software intended to reduce image noise in nuclear medicine imaging. Learn more about the software and its approved use on Spectrum Dynamics digital SPECT/CT system at by @soumya2390. #NuclearMedicine #MedicalImaging #DigitalHealth #AI #SPECTCT https://buff.ly/tqp0Sot http://Veritas.AI https://buff.ly/tqp0Sot http://Veritas.AI"
X Link 2026-02-13T16:01Z 26K followers, [--] engagements

"🔁 Friday Rewind with Xtalks Heres a quick catch-up on what crossed our radar this past week. Read about new partnerships investment plans an FDA-cleared at-home cancer treatment device and updated trackers on layoffs and deal activity. 🤝 AstraZeneca Partners with CSPC in a $1.2B Obesity and Metabolic Disease Deal Read the deal details: 💰 AstraZenecas $15B China Plan: More R&D and Manufacturing Through [----] See whats included: 🩺 FDA Clears Optune Pax for At-Home Treatment of Pancreatic Cancer Get the clearance update: 🏥 Healthcare Layoffs 2026: Track Current Job Cuts Browse the latest"
X Link 2026-02-13T20:09Z 26K followers, [--] engagements

"The FDA has issued a complete response letter for AstraZenecas subcutaneous anifrolumab in systemic lupus erythematosus (SLE). Heres what the decision means and what comes next at by @soumya2390. #FDA #SystemicLupusErythematosus #LupusResearch #Biologics #DrugRegulation https://buff.ly/xboxnic https://buff.ly/xboxnic"
X Link 2026-02-05T17:08Z 26K followers, [--] engagements

"Navigate the complexities of site selection in rare disease research with Paula Orandash and Benjamen Varsano in this strategic webinar hosted by Ergomed. They will demonstrate how a "three-pillar" landscape analysis uncovers critical insights that traditional historical data often misses. Register now to learn how early investment in patient-centric intelligence and real-world treatment patterns can shorten timelines improve recruitment feasibility and ensure more ethical study designs: #Ergomed #RareDisease #ClinicalTrials #LandscapeAnalysis #PatientEngagement #SiteSelection"
X Link 2026-02-06T11:24Z 26K followers, [--] engagements

"Before you log off heres your Friday Rewind a handful of device clearances a new presbyopia option three-year follow-up trial results for DMD a medtech M&A tracker and a World Cancer Day [----] perspective. 🦴 A Porous Titanium Take on an Expandable Fusion Platform Read the clearance update: 👁 Two Mechanisms One Drop: A New Presbyopia Option See whats approved: 🧬 Three-Year Follow-Up Adds Durability Context for Elevidys Review the data: 🏃 A New Knotless ACL Fixation System Clears FDA Review Get the 510(k) news: 💼 MedTech M&A 2026: The Deal Tracker to Bookmark Browse the roundup: 🟠 World"
X Link 2026-02-06T14:27Z 26K followers, [--] engagements

"Learn how to streamline your cell line development and master monoclonality assurance with Adam Causer in this technical webinar hosted by Nova Biomedical. Our expert will present an end-to-end workflow designed to achieve a 99.99% probability of clonality while automating the evidence-generation process for IND submissions. Register now to discover how to minimize "ghost well" risk through gentle single-cell deposition and leverage AI-powered analytics to maintain high throughput without sacrificing regulatory compliance. Broadcast [--] (UK EU Asia): Broadcast [--] (North America UK EU):"
X Link 2026-02-09T15:01Z 26K followers, [--] engagements

"Join us to explore the fundamental transformation of pharmaceutical logistics with Ilya Preston and Jeff Lander in this webinar hosted by PAXAFE. They will dive into Modernas strategic blueprint for an autonomous cold chain focusing on how decision intelligence and real-time visibility can eliminate "blind spots" and manual oversight. Register now to learn how a phased rollout can reduce product release delays and drive a shift toward a truly "hands-free" supply chain: #PAXAFE #Moderna #ColdChain #SupplyChain #Logistics #Pharmaceuticals #DecisionIntelligence #AutonomousLogistics"
X Link 2026-02-11T15:33Z 26K followers, [--] engagements

"In this episode INmune Bio CEO David Moss discusses targeting innate immunity therapeutically in diseases driven by chronic inflammation from the rare genetic disease RDEB to Alzheimers. Listen now at 🎙 https://buff.ly/Tze1NQm https://buff.ly/Tze1NQm"
X Link 2026-02-11T21:49Z 26K followers, [--] engagements

"The 7th issue of Xtalks Clinical Edge is here A special thanks to our front-cover interviewee Martin Beck Boehringer Ingelheim for sharing insights on improving awareness and patient-centered research in idiopathic pulmonary fibrosis. See more for [--] in-depth conversations with leaders advancing clinical research across therapeutic areas: 🧬 Immunology & Inflammatory Disease Paul F. Lizzul MD PhD MPH MBA AnaptysBio Niels Riedemann MD PhD InflaRx 👩🔬 Respiratory Research Martin Beck Boehringer Ingelheim Barry Quart PharmD Connect Biopharma 🧠 Neurology Ophthalmology & Ischemic Disease Ahmed"
X Link 2026-02-12T14:24Z 26K followers, [---] engagements

"The FDA has begun using a new inspection approach under QMSR aligning medical device inspections with ISO [-----] while maintaining existing regulatory authority. Read more about the regulatory update at by @soumya2390. #FDA #QMSR #MedicalDevices #RegulatoryAffairs #ISO13485 https://buff.ly/hHTDrx7 https://buff.ly/hHTDrx7"
X Link 2026-02-12T16:32Z 26K followers, [--] engagements

"Pharma touched down at [----] Super Bowl LX with drugmakers like Novartis Novo Nordisk and Boehringer Ingelheim using the Big Game to spotlight disease screening GLP-1 weight-loss drugs and more. Read more at #SuperBowlLX #PharmaAds #HealthAwareness https://buff.ly/gNZ5Oyj https://buff.ly/gNZ5Oyj"
X Link 2026-02-12T19:33Z 26K followers, [--] engagements

"Medtech layoffs in early [----] are affecting both device manufacturers and diagnostics companies with workforce reductions tied to site closures restructuring and contract changes. See whos getting affected at by @soumya2390. #MedtechLayoffs #MedicalDevices #MedtechIndustry #Diagnostics #Manufacturing https://buff.ly/SWcQVVQ https://buff.ly/SWcQVVQ"
X Link 2026-02-12T20:37Z 26K followers, [--] engagements

"Explore how to accelerate the transition from First-in-Human (FIH) to Proof-of-Concept (POC) with Aatir Butt in this webinar hosted by Fortrea. Our expert will discuss how adaptive study designs can eliminate "white space" between milestones enabling sponsors to respond dynamically to emerging data and streamline decision-making. Register now to learn how strategic site selection can enhance operational delivery and support the complex protocols of Phase I/Ib trials: #Fortrea #ClinicalTrials #EarlyPhase #PhaseI #DrugDevelopment #AdaptiveDesign #FirstInHuman #ProofOfConcept #Biotech"
X Link 2026-02-13T11:44Z 26K followers, [--] engagements

"On International Childhood Cancer Day [----] we look at recent FDA approvals early-stage trials and policy shifts shaping childhood cancer care. Explore the research landscape at by @soumya2390. #InternationalChildhoodCancerDay2026 #ICCD2026 #PediatricOncology #CancerResearch #HealthPolicy https://buff.ly/oiySKzq https://buff.ly/oiySKzq"
X Link 2026-02-15T14:38Z 26K followers, [--] engagements

"Theres a lot of competition in the arena which breeds success thats upcoming for the clinical trial world especially electronically says Janine Jones Clinical Solutions Specialist for @bioclinica when asked about the future of clinical trials #DIA2019"
X Link 2019-06-24T17:28Z 26K followers, [--] engagements

"Its like crossing Google with LinkedIn says @MarkLogics Imran Chaudhri about the companys Pharma Research Hub a data integration tool for clinical trials. #DIA2019 #ClinicalTrials"
X Link 2019-06-25T15:28Z 26K followers, [--] engagements

"Professionals Predict the Future of #ClinicalTrials Xtalks spoke with professionals gathered at DIA @DrugInfoAssn to get their take on what the future of clinical trials holds. @Synteract @SyneosHealth @MarkLogic @OmniCommSystems @Cluepoints @ICONplc https://buff.ly/2KUwn3e https://buff.ly/2KUwn3e"
X Link 2019-07-09T21:30Z 26K followers, [--] engagements

"Leaping Ahead in Cell Line Development with the Latest Technology What are the common challenges when setting up a Cell Line Development laboratory Register here to learn more: @solentim @ATUM_bio #DrugDevelopment #Biopharma #biotech #cellbiology https://buff.ly/2ZmrjuQ https://buff.ly/2ZmrjuQ"
X Link 2020-05-22T16:00Z 26K followers, [--] engagements

"Exploring Changes of Myeloid Cells with Chromogenic Multiplex IHC in Advanced #LiverCancer How is the #tumor microenvironment with multiplex #immunohistochemistry crucial for deciphering drug mechanisms of action on immune cells Learn more: @HalioDx https://buff.ly/36t6uiM https://buff.ly/36t6uiM"
X Link 2020-05-27T15:27Z 26K followers, [--] engagements

"A vaccine being developed by Swedish company @Diamyd has shown favorable safety and efficacy in a predefined genetic subset of type [--] diabetic patients. Read more about the trial & the promising results at by @AyeshaR1202 #vaccine #diabetes #type1diabetes https://buff.ly/3mlgeDg https://buff.ly/3mlgeDg"
X Link 2020-09-17T14:00Z 26K followers, [--] engagements

"Bioinformaticians use a combination of mathematics computer science and biology to help #scientists make sense of the data gathered from research projects. Read on to learn about job titles within #bioinformatics https://buff.ly/3dvV0iz https://buff.ly/3dvV0iz"
X Link 2021-05-30T19:30Z 26K followers, [--] engagements

"Join this webinar by @Oncodesign_SA to learn about how the DRIVE-MRT solution enables the rationalization design and optimization of targeted and effective #radiopharmaceuticals against specific #cancers. https://buff.ly/3pt8zXC https://buff.ly/3pt8zXC"
X Link 2021-10-23T16:00Z 26K followers, [--] engagements

"Medtronics MiniMed Go smart multiple daily injection (MDI) system has received the green light from the FDA. Integrated with Abbotts Instinct sensor it offers personalized automated insulin delivery. Read more at #Diabetes #CGM #Medtronic #MiniMed https://buff.ly/F1eFbaX https://buff.ly/F1eFbaX"
X Link 2026-01-22T15:30Z 26K followers, [--] engagements

"Cytokinetics has won FDA approval for Myqorzo (aficamten) for the treatment of symptomatic obstructive hypertrophic cardiomyopathy (oHCM) marking the companys first commercial product and its entry into a market led by Bristol Myers Squibbs Camzyos. Read more at #HCM #Cardiomyopathy #Myqorzo #Cytokinetics #FDAApproval https://buff.ly/1QfAGnX https://buff.ly/1QfAGnX"
X Link 2026-01-26T15:34Z 26K followers, [----] engagements

"Removing the Risk in #RiskBased Monitoring Upcoming live #webinar with @CluePoints http://buff.ly/2bGaXny http://buff.ly/2bGaXny"
X Link 2016-09-01T16:01Z 26K followers, [--] engagements

"Join @FoxBigData @BurrellAnita @NTTDATAServices @Adam_L_Nelson & our very own @SarahHandMSc for a live #TwitterChat TODAY at 11AM EDT and weigh in on the challenges of #realworldevidence and #realworlddata in #healthcare #MarkLogicChat"
X Link 2018-04-18T14:00Z 26K followers, [--] engagements

"Research into alternative stem cell sources has identified urine derived renal progenitor cells (UdRPCs) as a possible option for use in regenerative kidney therapies in the future. #stemcell #kidney #urine https://buff.ly/37geaDW https://buff.ly/37geaDW"
X Link 2020-02-12T04:00Z 26K followers, [--] engagements

"Management of Gram-positive Bloodstream Infections: Collaboration Perspectives from the Laboratory and Antimicrobial Stewardship What are the roles of a #clinical #microbiology laboratory and #antimicrobial stewardship team @GenMark_Dx https://buff.ly/3isq9DW https://buff.ly/3isq9DW"
X Link 2020-10-08T00:00Z 26K followers, [--] engagements

"Smart Manufacturing Meets the Bioreactor: Driving More Value and Consistency from Bioprocessing How are #bioreactor analytics compatible with continuous manufacturing as a seamless path for future #Pharma [---] initiatives #QualityControl @aizon_ai_ https://buff.ly/2MimnCD https://buff.ly/2MimnCD"
X Link 2021-01-27T19:30Z 26K followers, [--] engagements

"Artificial Intelligence in Digital Pathology Image analysis is an essential part of digital pathology. Do you know which artificial intelligence method will work best with your image data Sign up to learn #DigitalPathology #Imaging #AI @Visiopharm https://buff.ly/3qhupKh https://buff.ly/3qhupKh"
X Link 2021-03-09T15:00Z 26K followers, [--] engagements

"How to Navigate the Health Canada XML PM Requirements As we enter [----] the @GovCanHealth mandates and timelines become more important than ever. Register now to learn about the #submission requirements for #drugproduct information by @ReedTechLifeSci. https://buff.ly/3ddzezV https://buff.ly/3ddzezV"
X Link 2021-03-27T16:00Z 26K followers, [--] engagements

"Register for this webinar to gain deeper insight into DRIVE-SM (DRug Integrative discovery for small molecule) premium Integrated Drug Discovery Services. #PrecisionMedicine #Oncology #DNA @Oncodesign_SA https://buff.ly/3fYs3OQ https://buff.ly/3fYs3OQ"
X Link 2021-04-26T18:30Z 26K followers, [--] engagements

"Did you know #MolecularGuidanceSystems or MGSs can be rapidly identified for virtually any #celltype Sign up for this webinar by @SRI_Intl to hear how MGSs can deliver a wide variety of cargoes ranging from small molecules to full length #antibodies. https://buff.ly/3wc8ebM https://buff.ly/3wc8ebM"
X Link 2021-05-19T21:30Z 26K followers, [--] engagements

"Preventative genomics company @phosphorus has developed a comprehensive preventative #genetic test that not only screens for #disease risk but also provides information on #health and wellness indicators. Read more about the test by @AyeshaR1202. https://buff.ly/2UWTVug https://buff.ly/2UWTVug"
X Link 2021-07-19T16:01Z 26K followers, [--] engagements

"This presentation by @SyngeneIntl will give the audience a good understanding of key questions to enable decision for way-forward #riskanalysis and #mitigation strategies parameter selection and evaluation for technology transfer. https://buff.ly/3qGtEMO https://buff.ly/3qGtEMO"
X Link 2021-07-30T14:00Z 26K followers, [--] engagements

"In this webinar @AliveCor will deliver real-world examples of Decentralized #ClinicalTrials showing how implementing user-friendly #digitalhealth devices improves overall #patient experience. Sign up today https://buff.ly/3yCeuKD https://buff.ly/3yCeuKD"
X Link 2021-09-03T21:30Z 26K followers, [--] engagements

"Join this webinar to learn about how @SyngeneIntl performed an overall assessment and defined the phase-appropriate quality systems covering #preclinical research to #clinical-phase studies. https://buff.ly/3rcaYGR https://buff.ly/3rcaYGR"
X Link 2021-12-02T19:30Z 26K followers, [--] engagements

"Researchers at @ChildrensPhila developed a new #bioinformatics software tool called CancerVar. Read more by @VeraKovacevic3 to learn how CancerVar helps with the clinical interpretation of somatic mutations in #cancer. https://buff.ly/38k9ovD https://buff.ly/38k9ovD"
X Link 2022-05-12T14:00Z 26K followers, [--] engagements

"Faster to produce than conventional #vaccines the potential applications of synthetic #mRNA to prevent illness and treat diseases seems nearly limitless. Read more here. https://buff.ly/3MgwxO7 https://buff.ly/3MgwxO7"
X Link 2022-05-15T19:30Z 26K followers, [--] engagements

"Xtalks had a discussion with @BONESUPPORT_AB CEO Emil Billbck about Cerament G the first and only bone graft with antibiotic elution that is approved for the US market. You can read the interview with Emil Billbck at by @VeraKovacevic3. https://buff.ly/38D3Ex6 https://buff.ly/38D3Ex6"
X Link 2022-06-03T03:00Z 26K followers, [--] engagements

"In this Xtalks Spotlight discussion Xtalks spoke with Rachel Colite Vice President of Decentralized Clinical Trials at @Cogstate who shared trends considerations and benefits of remote and decentralized clinical trial implementation. #ClinicalTrials https://buff.ly/3nJaViN https://buff.ly/3nJaViN"
X Link 2022-07-06T16:30Z 26K followers, [--] engagements

"Xtalks had a discussion with Devon Adams Senior Analyst for Policy & Legislative Support at @ACSCAN about improving patient access to #clinicaltrials decentralized approaches for #oncology trials & more. Read the full interview by @VeraKovacevic3 here. https://buff.ly/3XMgf5L https://buff.ly/3XMgf5L"
X Link 2022-11-30T23:11Z 26K followers, [--] engagements

"The US Food and Drug Administration (FDA) has approved Luye Pharmas Rykindo for the treatment of #schizophrenia and as a monotherapy or adjunctive #therapy for the maintenance treatment of #bipolardisorder in adults. Read more on this story here: https://buff.ly/3HDuG64 https://buff.ly/3HDuG64"
X Link 2023-01-29T17:00Z 26K followers, [---] engagements

"The application of whole genome sequencing (WGS) to derive a more complete understanding of cancer has been a central goal of #cancer researchers even before the first human genome was decoded in [----]. #Bioinformatics #HumanGenome https://buff.ly/3oD5G8i https://buff.ly/3oD5G8i"
X Link 2023-05-14T15:30Z 26K followers, [----] engagements

"In this episode Xtalks interviews two experts from CytoMed Therapeutics Mr. Choo Chee Kong & Dr. Tan Wee Kiat about the companys mission to develop more affordable #cellular #cancer therapies the launch of the companys new IPO & more. Listen here: https://buff.ly/3PNLZWJ https://buff.ly/3PNLZWJ"
X Link 2023-07-09T15:30Z 26K followers, [---] engagements

"This podcast episode features an interview with Dr. William Williams CEO of @BriaCell which is focused on developing novel immunotherapies in cancer. Listen now: #Oncology #CellTherapy #ClinicalTrials https://buff.ly/45wwQ0Z https://buff.ly/45wwQ0Z"
X Link 2023-08-30T16:27Z 26K followers, [---] engagements

"Karuna Therapeutics revealed Phase III EMERGENT-2 trial results for their investigational drug KarXT in #schizophrenia published in The Lancet. Read more about the clinical trial data at #ClinicalResearch #Psychiatry #NeuroscienceClinicalTrials https://buff.ly/3NXilNd https://buff.ly/3NXilNd"
X Link 2023-12-26T11:30Z 26K followers, [---] engagements

"We spoke with Dr. Taylor H. Schreiber CEO and Co-Founder of Shattuck Labs about the companys pioneering approach to developing dual-function fusion proteins for the treatment of #cancer and #autoimmunediseases. Read more by @VeraKovacevic3: #Biologics https://buff.ly/3Pv7E5h https://buff.ly/3Pv7E5h"
X Link 2024-03-05T15:04Z 26K followers, [---] engagements

"✅ @Mercks Winrevair received FDA approval as the first-in-class treatment for pulmonary arterial hypertension (PAH). Read about the biologic which Merck acquired in its $11.5 acquisition of Acceleron & its approval: #RareDisease #PulmonaryHypertension https://buff.ly/49dWVmE https://buff.ly/49dWVmE"
X Link 2024-04-02T10:00Z 26K followers, [---] engagements

"📰 Sagimet Biosciences' oral FASN inhibitor denifanstat is advancing to Phase III trials for MASH. The study set to start by year-end aims to enroll [----] patients. Read more at by @AyeshaR1202. https://buff.ly/3Avsb59 https://buff.ly/3Avsb59"
X Link 2024-11-06T14:03Z 26K followers, [---] engagements

"📰 Journey Medical has received FDA approval for its rosacea drug Emrosi. Read more at by @AyeshaR1202 about the drug and how Journey is hoping it could rival the current standard-of-care treatment for rosacea. #Rosacea #Dermatology https://buff.ly/3AwcwCJ https://buff.ly/3AwcwCJ"
X Link 2024-11-07T22:30Z 26K followers, [---] engagements

"The complexity of biological systems poses challenges in drug discovery. Join our virtual event by Akoya Biosciences to learn how advancements in spatial biology can optimize therapeutic development: #SpatialBiology #DrugDiscovery #Webinar https://buff.ly/4enxBxe https://buff.ly/4enxBxe"
X Link 2024-11-11T15:30Z 26K followers, [---] engagements

"Roche's $1.5B acquisition of Poseida Therapeutics is set to advance off-the-shelf CAR-T treatments. With scalable solutions patients battling cancers and autoimmune diseases could soon see faster accessible therapies. Learn more at by @soumya2390. https://buff.ly/3OwbU3i https://buff.ly/3OwbU3i"
X Link 2024-11-29T16:55Z 26K followers, [---] engagements

"Jupiter Neurosciences launches its $11M IPO on Nasdaq aiming to advance its investigational drug Jotrol a resveratrol-based innovation targeting CNS disorders like Parkinsons and Alzheimers. Explore their platform and partnerships at by @soumya2390. https://buff.ly/3ZgDnem https://buff.ly/3ZgDnem"
X Link 2024-12-05T14:11Z 26K followers, [---] engagements

"In this episode hear from Kairos Pharmas CEO Dr. Yu about the companys focus on developing therapeutics that counter cancer drug resistance. Listen now at 🎙 https://buff.ly/3ZfGinq https://buff.ly/3ZfGinq"
X Link 2024-12-05T21:37Z 26K followers, [---] engagements

"Neurocrine Biosciences Crenessity (crinecerfont) has been approved as the first new treatment in decades for the rare genetic disorder congenital adrenal hyperplasia (CAH). Read more at by @AyeshaR1202 about the approval. https://buff.ly/401RSnK https://buff.ly/401RSnK"
X Link 2024-12-18T21:30Z 26K followers, [---] engagements

"Zhengye Biotechnologys IPO positions the company for rapid growth in the global veterinary vaccine market. With $6M raised Zhengye plans to expand its vaccine portfolio enhancing animal health worldwide. Learn more at by @soumya2390. https://buff.ly/4j6091A https://buff.ly/4j6091A"
X Link 2025-01-13T19:01Z 26K followers, [---] engagements

"Ascentage Pharma's IPO brings a new wave of targeted therapies such as olverembatinib and lisaftoclax for hematological cancers. Learn more about the companys innovative approach at by @soumya2390. https://buff.ly/42wPaZp https://buff.ly/42wPaZp"
X Link 2025-01-28T19:50Z 26K followers, [---] engagements

"Maze Therapeutics has arrived with its IPO offering bringing with it genetically targeted treatments aimed at APOL1-mediated kidney disease. Learn more at by @soumya2390. https://buff.ly/3CBtdO9 https://buff.ly/3CBtdO9"
X Link 2025-02-04T21:16Z 26K followers, [---] engagements

"Beta Bionics has successfully raised $234.6 million from its IPO which will fund the commercialization and clinical trials of its flagship product the iLet bionic pancreas system. Learn more about the insulin dosing management system at by @soumya2390. https://buff.ly/3Qd3uPb https://buff.ly/3Qd3uPb"
X Link 2025-02-11T14:30Z 26K followers, [---] engagements

"Sionna Therapeutics IPO has arrived in the cystic fibrosis landscape. Leveraging innovative NBD1 stabilizers its lead candidates SION-719 and SION-451 are currently in Phase I trials targeting the critical F508del mutation. More at by @soumya2390. https://buff.ly/4ia0IGw https://buff.ly/4ia0IGw"
X Link 2025-02-21T17:30Z 26K followers, [---] engagements

"Aardvark Therapeutics IPO launches with $94.2M in capital fueling breakthrough research in hyperphagia and Prader-Willi syndrome. Learn more about Aardvarks next-gen pipeline for metabolic diseases at by @soumya2390. https://buff.ly/3XcgGb2 https://buff.ly/3XcgGb2"
X Link 2025-02-24T12:51Z 26K followers, [---] engagements

"Kestra Medical Technologies IPO raises $202M bolstering its wearable cardioverter defibrillator and digital health platform. Learn more about Kestra at by @soumya2390. https://buff.ly/4wvzVKX https://buff.ly/4wvzVKX"
X Link 2025-03-17T13:44Z 26K followers, [---] engagements

"Advanced Biomeds IPO raised $6.56M fueling innovative liquid biopsy testing for early cancer detection. Discover how their microfluidic platform could advance cancer diagnostics for better patient outcomes at by @soumya2390. https://buff.ly/hR80rJD https://buff.ly/hR80rJD"
X Link 2025-03-17T19:46Z 26K followers, [---] engagements

"Roche and Zealand Pharma are teaming up in a $5.3B deal to co-develop petrelintide a next-gen obesity therapy. With potential for best-in-class efficacy and a novel combo approach learn more about this major move by @soumya2390 at https://buff.ly/AhKmTKW https://buff.ly/AhKmTKW"
X Link 2025-03-18T11:27Z 26K followers, [---] engagements

"✨ The 200th episode of the Xtalks Life Science Podcast is here Hear from Coya Therapeutics CEO Dr. Arun Swaminathan as he discusses the companys innovative immunotherapeutic approach to enhancing Treg function in diseases like ALS and Alzheimers at https://buff.ly/q2VMFwu https://buff.ly/q2VMFwu"
X Link 2025-03-19T13:49Z 26K followers, [---] engagements

"In this episode Unicycive Therapeutics founder and CEO Dr. Shalabh Gupta discusses the current unmet needs in kidney diseases and Unicycives innovative approaches to addressing them. Listen now at 🎙 https://buff.ly/J2LvFyw https://buff.ly/J2LvFyw"
X Link 2025-03-26T20:23Z 26K followers, [---] engagements

"In this episode Vera Therapeutics founder and CEO Dr. Marshall Fordyce discusses the current landscape of autoimmune diseases and how his company is innovating treatments for IgA nephropathy. Listen now at 🎙 https://buff.ly/PxDYf0L https://buff.ly/PxDYf0L"
X Link 2025-04-03T19:39Z 26K followers, [---] engagements

"Cuprina Holdings IPO raises $12M to fund bio-dressings for diabetic foot venous leg and pressure ulcers powered by maggot therapy and collagen from bullfrog-skin waste. Learn more about the IPO at by @soumya2390. https://buff.ly/oevHRsi https://buff.ly/oevHRsi"
X Link 2025-04-16T18:32Z 26K followers, [---] engagements

"Soleno Therapeutics Vykat XR received FDA approval for hyperphagia in patients with Prader-Willi syndrome (PWS). Read more at by @AyeshaR1202 about the treatment. https://buff.ly/1YK8NjX https://buff.ly/1YK8NjX"
X Link 2025-04-16T21:29Z 26K followers, [---] engagements

"Precision psychiatry is reshaping neuropsychiatric clinical trials. Alto Neurosciences Dr. Amit Etkin discusses how harnessing biomarkers EEG and wearables to tailor therapies can cut placebo noise and boost success. Read more in our Xtalks Clinical Edge feature at by @AyeshaR1202. https://buff.ly/CZRiP8C https://buff.ly/CZRiP8C"
X Link 2025-05-14T12:11Z 26K followers, [---] engagements

"Apimeds Pharmaceuticals US IPO brings a fresh angle to drug development: intradermal bee venom delivery. With plans for a new Phase III trial learn more about this unique approach at by @soumya2390. https://buff.ly/BkYT02e https://buff.ly/BkYT02e"
X Link 2025-05-21T20:23Z 26K followers, [---] engagements

"Hinge Health IPO debuts at $437.3M merging AI wearables and human care to advance musculoskeletal health. Explore how their FDA-cleared Enso device and TrueMotion tech aim to reshape pain care at by @soumya2390. https://buff.ly/gEYhbwQ https://buff.ly/gEYhbwQ"
X Link 2025-05-29T20:56Z 26K followers, [---] engagements

"❓ How can we avoid hidden pitfalls in bioinformatics workflows Join Bullfrog AIs webinar with Juan Felipe Beltrn to explore common issues in AI-powered computational biology workflows including mismanaging compositional data overinterpreting ML feature importance and misapplying generative AI for ranking tasks. Register now: #Bioinformatics #MachineLearning #AIinBioinformatics #DrugDiscovery #BioinformaticsChallenges #BullfrogAI https://buff.ly/xzyNeGx https://twitter.com/i/web/status/1931020102456975686 https://buff.ly/xzyNeGx https://twitter.com/i/web/status/1931020102456975686"
X Link 2025-06-06T16:07Z 26K followers, [---] engagements

"The Omada Health IPO is official. The company raised $120M to expand its digital programs for musculoskeletal diabetes and GLP-1 support. We explore whats next for Omada and what the filing reveals at by @soumya2390. https://buff.ly/bD2KZjo https://buff.ly/bD2KZjo"
X Link 2025-06-20T20:25Z 26K followers, [---] engagements

"Caris Life Sciences is building an AI-led diagnostics and oncology drug discovery engine backed by $494M from its [----] IPO. Our article by @soumya2390 at walks through the companys tools partnerships and where it's headed. https://buff.ly/dHgVmrQ https://buff.ly/dHgVmrQ"
X Link 2025-06-25T20:17Z 26K followers, [---] engagements

"Shoulder Innovations just raised $75M in its NYSE IPO to expand its AI-powered planning implant lineup & outpatient-friendly tools for shoulder surgery. Learn how this medtech debut supports arthroplasty innovation at by @soumya2390. #ShoulderInnovationsIPO #ShoulderSurgery #MedicalDevices #Orthopedics #Arthroplasty #IPO2025 #SurgicalInnovation #HealthcareInvesting #ReverseShoulder #AnatomicShoulder https://buff.ly/NsxUMa7 https://buff.ly/NsxUMa7 https://buff.ly/NsxUMa7 https://buff.ly/NsxUMa7"
X Link 2025-08-12T14:57Z 26K followers, [---] engagements

"Who employs the most in pharma and healthcare 🌍 From biotech titans and legacy pharma to retail pharmacy giants and global CROs workforce size tells a powerful story of influence scale and global reach. 🔹 CVS Health and Walgreens Boots Alliance top the list not for R&D but for their vast retail and insurance operations. 🔹Johnson & Johnson Pfizer Roche and AstraZeneca remain R&D powerhouses with global commercial infrastructure. 🔹Sinopharm and CR Pharma companies based in China are rapidly scaling. 🔹Europe continues to lead with Sanofi Novo Nordisk Bayer and Novartis maintaining large"
X Link 2025-08-15T19:43Z 26K followers, [---] engagements

"Dr. Marshall Fordyce Founder and CEO of @Official_VeraTx shares how a science-first strategy is driving progress in IgA nephropathy (IgAN) and beyond. From designing rigorous trials to embedding patient and physician voices at every step Vera Therapeutics is redefining what it means to develop targeted patient-centered therapies. Read the full story in this Xtalks Clinical Edge interview at by Mohammad Ali. #AutoimmuneDiseases #IgAN #KidneyHealth #CKD #ClinicalResearch #DrugDevelopment #PatientCentricity #LifeSciences #Biotech #Pharma #XtalksClinicalEdge https://buff.ly/ElYX32u"
X Link 2025-08-27T16:40Z 26K followers, [---] engagements

"Picard Medical IPO raises $19.55M on NYSE American. Parent of SynCardia the company develops the only FDA- and Health Canada-approved total artificial heart. Learn what this means for patients at by @soumya2390. #PicardMedicalIPO #PicardMedical #SynCardia #ArtificialHeart #MedicalDevices #HeartFailure #BiventricularFailure #CardiacCare #MedTech #Cardiology #MedicalTechnology https://twitter.com/i/web/status/1969078818531885254 https://buff.ly/3YrNn7D https://twitter.com/i/web/status/1969078818531885254 https://buff.ly/3YrNn7D"
X Link 2025-09-19T16:39Z 26K followers, [---] engagements

"🧬 How can you decode the tumor microenvironment to accelerate therapeutic discovery Join QIAGEN for a webinar with Kristin OMalley to explore how curated biological knowledge and predictive modeling tools can help translational scientists make sense of complex omics data. Learn how to construct molecular networks interpret gene expression datasets and predict immune and tumor behavior including insights from Interleukin1 beta in NSCLC. Register now: #TumorMicroenvironment #PredictiveModeling #TranslationalScience #QIAGEN #OncologyResearch https://buff.ly/C0Ookw4 https://buff.ly/C0Ookw4"
X Link 2025-09-22T10:21Z 26K followers, [---] engagements

"❓ How can you turn messy clinical PDFs into analysis-ready datasets without losing human oversight Join BullFrog AIs webinar with Juan Felipe Beltrn Lacouture PhD to learn how bfPREPTM and bfLEAPTM streamline clinical data intake entity resolution and OMOP structuring. Discover practical templates agent-powered workflows and verified automation strategies that preserve human judgment while accelerating analysis-ready outputs. Register now: #ClinicalData #DataAutomation #OMOP #MachineLearning #BullFrogAI #AgenticAI https://buff.ly/xvx6klK https://twitter.com/i/web/status/1971571748760879542"
X Link 2025-09-26T13:45Z 26K followers, [---] engagements

"FDA approves Vizz (aceclidine eye drops) for presbyopia a non-surgical option for adults with age-related near vision loss. Learn how LENZ Therapeutics once-daily drop restores focus for up to [--] hours at by @soumya2390. #Vizz #Aceclidine #LENZTherapeutics #FDAApproval #Presbyopia #EyeCare #Ophthalmology #VisionHealth #PharmaNews #DrugDevelopment #EyeDrops #AgeRelatedVisionLoss #HealthcareNews #LifeSciences #EyeTreatment #FDA #PrescriptionDrugs https://buff.ly/PCIMwGo https://buff.ly/PCIMwGo"
X Link 2025-10-20T20:42Z 26K followers, [---] engagements

"With $285M from its IPO LB Pharmaceuticals will fund new trials of its investigational drug LB-102 for schizophrenia and bipolar depression. Explore how this biopharma is advancing neuropsychiatry care at by @soumya2390. #LBPharmaceuticals #LBRX #LBPharmaIPO #Biotech #Neuropsychiatry #SchizophreniaResearch #BipolarDepression #ClinicalTrials #InvestigationalDrug https://buff.ly/hNn53j1 https://buff.ly/hNn53j1 https://buff.ly/hNn53j1 https://buff.ly/hNn53j1"
X Link 2025-10-24T14:26Z 26K followers, [--] engagements

"Novartis is making a $12B move into RNA therapeutics with the acquisition of Avidity Biosciences. The deal adds Aviditys RNA platform and late-stage programs for Duchenne DM1 and FSHD bolstering Novartiss neuromuscular disease pipeline. Read more at #RNAtherapeutics #DuchenneMuscularDystrophy #MergersAndAcquisitions #Novartis #AvidityBiosciences https://buff.ly/s99ur59 https://twitter.com/i/web/status/1985416691166175627 https://buff.ly/s99ur59 https://buff.ly/s99ur59 https://twitter.com/i/web/status/1985416691166175627 https://buff.ly/s99ur59"
X Link 2025-11-03T18:40Z 26K followers, [---] engagements

"MapLight Therapeutics IPO raised around $296M to fund Phase II trials of its muscarinic-based therapy for schizophrenia and Alzheimers psychosis. Learn how this clinical-stage biotech is advancing CNS drug discovery at by @soumya2390. #MapLightTherapeutics #BiotechIPO #CNS #DrugDiscovery #Neuroscience https://buff.ly/vuGdJxZ https://buff.ly/vuGdJxZ https://buff.ly/vuGdJxZ https://buff.ly/vuGdJxZ"
X Link 2025-11-03T19:42Z 26K followers, [---] engagements

"Bausch + Lombs campaign for dry eye disease treatment Miebo features American sportscaster Erin Andrews with an ad spot showing her battling gritty eyes and at pop ups in New York. Read more at #DryEyeDisease #Bausch+Lomb https://buff.ly/Mwj4Mcv https://buff.ly/Mwj4Mcv"
X Link 2025-11-06T15:30Z 26K followers, [---] engagements

"Ivonescimab delivers survival benefits in EGFR-mutant NSCLC. Final trial data from China show improved PFS and OS with ivonescimab + chemo vs chemo alone. Makers Akeso and Summit Therapeutics plan to submit a BLA in Q4 [----]. Read more at #Ivonescimab #LungCancer #NSCLC #Oncology #Akeso #ClinicalTrials https://buff.ly/hTbgwUr https://buff.ly/hTbgwUr"
X Link 2025-12-01T14:22Z 26K followers, [---] engagements

"Designing more effective meaningful trials for IPF and other rare respiratory diseases requires new thinking. Thermo Fisher Scientifics Francis Jones PhD shares the strategies redefining study design including biomarker-driven selection better patient engagement and technology-enabled data capture. Watch the video and read more at by @VeraKovacevic3. #ClinicalTrials #ClinicalResearch #RareDisease #RespiratoryDisease #IPF https://buff.ly/34xaS8B https://twitter.com/i/web/status/1999227666579308725 https://buff.ly/34xaS8B https://twitter.com/i/web/status/1999227666579308725"
X Link 2025-12-11T21:19Z 26K followers, [--] engagements

"Structure Therapeutics reported positive Phase II data for its oral GLP-1 agonist aleniglipron in adults with obesity or overweight. The results support plans for Phase III development. Dive into the clinical trial data at by @soumya2390. #StructureTherapeutics #ClinicalTrials #ObesityResearch #GLP1 #Aleniglipron https://twitter.com/i/web/status/2000603899795812707 https://buff.ly/DxWvAuR https://twitter.com/i/web/status/2000603899795812707 https://buff.ly/DxWvAuR"
X Link 2025-12-15T16:28Z 26K followers, [--] engagements

"Thermo Fisher Scientifics Francis Jones PhD shares how precision medicine meaningful endpoints and evolving technologies are influencing study design for IPF and other rare respiratory diseases. Watch the video and read more at by @VeraKovacevic3. #ClinicalTrials #ClinicalResearch #RareDisease #RespiratoryDisease #IPF https://buff.ly/34xaS8B https://twitter.com/i/web/status/2001628590350237821 https://buff.ly/34xaS8B https://buff.ly/34xaS8B https://twitter.com/i/web/status/2001628590350237821 https://buff.ly/34xaS8B"
X Link 2025-12-18T12:20Z 26K followers, [--] engagements

"Eli Lillys next-generation obesity drug #retatrutide outperformed its current blockbuster Zepbound in a late-stage trial delivering greater weight loss and easing knee pain in patients with osteoarthritis. Read more: #EliLilly #ClinicalTrials #ObesityDrugs #WeightLossDrugs #GLP1Drugs #Zepbound https://twitter.com/i/web/status/2001819808992550942 https://buff.ly/xfUq30t https://twitter.com/i/web/status/2001819808992550942 https://buff.ly/xfUq30t"
X Link 2025-12-19T01:00Z 26K followers, [---] engagements

".@EliLillyandCo announces its roster of Team USA athletes for Milano Cortina [----] and pledges to turn Olympic and Paralympic milestones into meaningful community impact. Every medal earned will support US nonprofits improving health access: #EliLilly #TeamUSA #MilanoCortina2026 #HealthEquity #CommunityHealth #Olympics #Paralympics #Lilly https://buff.ly/2Fu0w8U https://twitter.com/i/web/status/2008205188457238656 https://buff.ly/2Fu0w8U https://buff.ly/2Fu0w8U https://twitter.com/i/web/status/2008205188457238656 https://buff.ly/2Fu0w8U"
X Link 2026-01-05T15:53Z 26K followers, [--] engagements

"Learn how to accelerate drug development through master protocol trial designs with Melanie Owen MS Susie Cain RAC and Song Wang in this webinar hosted by Thermo Fisher Scientific. They will explore how evaluating multiple investigational products under a single infrastructure streamlines coordination and provides the adaptive design flexibility needed to modify studies based on treatment performance. Register now to gain insights into implementing these complex clinical trials to improve decision-making and eliminate the need for redundant trial protocols: #ThermoFisherScientific #PPD"
X Link 2026-01-08T16:23Z 26K followers, [---] engagements

"With its Nasdaq debut Aktis Oncology is funding Phase Ib programs in urothelial and other solid tumors using targeted alpha radiopharmaceuticals. Read about its miniprotein platform and manufacturing plans at by @soumya2390. #Radiopharmaceuticals #AktisOncology #BiotechIPO https://buff.ly/xP7evHv https://buff.ly/xP7evHv https://buff.ly/xP7evHv https://buff.ly/xP7evHv"
X Link 2026-01-28T21:37Z 26K followers, [--] engagements

"Zepbounds latest TV commercial brings $299 self-pay into focus. Our article breaks down the ads message access options and recent clinical updates across Lillys obesity portfolio at by @soumya2390. #Zepbound #ObesityTreatment #GLP1 #PharmaAdvertising #WeightManagement https://buff.ly/4v8MsMt https://buff.ly/4v8MsMt https://buff.ly/4v8MsMt https://buff.ly/4v8MsMt"
X Link 2026-01-28T21:39Z 26K followers, [--] engagements

"The Gates Foundation and OpenAI have launched a $50M initiative to support the use of AI in primary care across Africa starting in Rwanda. We examine what Horizon1000 aims to do and how AI could support clinicians facing workforce shortages at by @soumya2390. #GatesFoundation #OpenAI #AfricaHealthcare #ArtificialIntelligence #PrimaryCare https://buff.ly/Ow2wvzk https://buff.ly/Ow2wvzk https://buff.ly/Ow2wvzk https://buff.ly/Ow2wvzk"
X Link 2026-01-29T11:42Z 26K followers, [--] engagements

"New Phase II data from Roche show sustained weight loss with CT-388 a dual-hormone therapy being studied for obesity. Read the full story at by @soumya2390. #Roche #CT388 #ObesityResearch #GLP1 #GIP https://buff.ly/PPMiMon https://buff.ly/PPMiMon"
X Link 2026-01-29T12:42Z 26K followers, [--] engagements

"Explore the transformative potential of in vivo CAR T-cell therapies with Juliana Campo Garcia in this technical webinar hosted by GenScript. She will examine how mRNA and lipid nanoparticle (LNP) technologies enable transient controlled CAR expression and targeted delivery directly to immune cells. Register now to gain insights into optimizing platform selection LNP formulation and analytical testing to overcome the common challenges of developing next-generation in vivo immunotherapies: #GenScript #CARTcellTherapy #mRNA #LNPs #InVivo #GeneTherapy #Immunotherapy #Biotech #DrugDelivery"
X Link 2026-01-29T14:29Z 26K followers, [--] engagements

"Learn how to deliver more with less through centralized FSP models with Suchela Srivatsa and Claire Rielly in this webinar by IQVIA. They will provide a practical stepwise playbook for modernizing clinical operations focusing on how to "right-shore" high-volume tasks like eTMF intake and site visit report reviews to standardize quality and reduce costs. Register now to explore how the framework improves inspection readiness and global oversight while maintaining full control over your data: #IQVIA #ClinicalOperations #FSP #ClinicalTrials #PharmaEfficiency #RightShoring #InspectionReadiness"
X Link 2026-01-30T14:40Z 26K followers, [--] engagements

"Sarepta released new 3-year trial data examining long-term outcomes and safety for Elevidys in Duchenne muscular dystrophy (DMD) a rare childhood muscle disease. Read more about the clinical trial at by @soumya2390. #Elevidys #DuchenneMuscularDystrophy #GeneTherapy #RareDisease https://buff.ly/hOyeD9k https://buff.ly/hOyeD9k https://buff.ly/hOyeD9k https://buff.ly/hOyeD9k"
X Link 2026-01-30T19:14Z 26K followers, [---] engagements

"Evaluate how early protocol design decisions impact clinical supply strategy and RTSM performance with Jennifer Cobb Foulkes Jennifer Teti Savannah Holt and Jonathan Pritchard in this collaborative webinar hosted by 4G Clinical. They will examine how specific design choices from kit architecture and expiry strategy to pooling models and resupply logic directly shape trial execution and influence forecasting accuracy. Register now to learn how to bridge the gap between protocol intent and operational readiness while exploring how emerging AI technologies are transforming the future of supply"
X Link 2026-02-02T14:25Z 26K followers, [--] engagements

"Each biologic has its own unique formulation challenges. Madison White Senior Scientist at FUJIFILM Biotechnologies discusses how a structured data-rich formulation approach can help de-risk development and support preclinical readiness. Read more at #Biologics #Formulation #Biotech #FUJIFILMBiotechnologies https://buff.ly/TpDjs4Y https://buff.ly/TpDjs4Y https://buff.ly/TpDjs4Y https://buff.ly/TpDjs4Y"
X Link 2026-02-02T14:26Z 26K followers, [--] engagements

"In this episode hear Domp Chief Development Officer Dr. Ahmed Enayetallah discuss innovative therapeutic approaches based on nerve growth factor (NGF) biology in ocular diseases with high unmet need such as NAION. Listen now at 🎙 https://buff.ly/QIjM0Nr https://buff.ly/QIjM0Nr"
X Link 2026-02-04T20:40Z 26K followers, [--] engagements

"Explore how community-based trial models prioritize the patient experience with Deon Miller DO Nancy Lizzul and Lou Cappoli in this webinar hosted by EmVenio Clinical Research. They will share real-world data on how localized engagement strategies including community-site networks and mobile research units overcome traditional barriers to improve enrollment and retention. Register now to learn how these models strengthen patient trust and provide the key metrics needed to advance health equity and inclusivity across diverse therapeutic areas: #EmVenio #ClinicalResearch #CommunityBasedResearch"
X Link 2026-02-05T11:19Z 26K followers, [--] engagements

"#MedicalDevice Innovation: Blurring the Lines Between Medical Necessity & Personal Accessory http://t.co/PPgHn33Fdm http://t.co/5HT1tgAURK http://buff.ly/1JUs8Jo http://buff.ly/1JUs8Jo"
X Link 2015-09-10T15:35Z 26K followers, [--] engagements

"Roche Collaborates With SQZ #Biotech Startup On Immuno-Oncology Treatments http://buff.ly/1HSBnP3 http://buff.ly/1HSBnP3"
X Link 2015-12-08T20:00Z 26K followers, [--] engagements

"Stay up to date in the #LifeScience #Biotech and #Pharmaceutical industries with our daily http://buff.ly/1jT23nh http://buff.ly/1jT23nh"
X Link 2015-12-12T20:01Z 26K followers, [--] engagements

"Dissolvable Brain Sensor Developed To Monitor #Patients With #TraumaticBrainInjury http://buff.ly/1nm3Kw5 http://buff.ly/1nm3Kw5"
X Link 2016-01-20T23:00Z 26K followers, [--] engagements

"ICYMI: [--] Reasons Why #Pharma Marketers Are Failing At #SocialMedia http://buff.ly/1VdI6Ew http://buff.ly/1VdI6Ew"
X Link 2016-01-23T23:00Z 26K followers, [--] engagements

"How To Start A #Biotech Company On A Dime Featuring @theBentoLab & @nanopore http://buff.ly/1rlvZww http://buff.ly/1rlvZww"
X Link 2016-04-28T20:30Z 26K followers, [--] engagements

"#DigitalHealth and the Emerging Vital Role of Electronic Data Capture(#EDC) http://buff.ly/293CTRZ http://buff.ly/293CTRZ"
X Link 2016-06-28T22:01Z 26K followers, [--] engagements

"Why You Should Be Constructing Buyer #Personas When Hosting A #Webinar (& How To Do It) http://buff.ly/29HQ6h1 http://buff.ly/29HQ6h1"
X Link 2016-07-04T13:52Z 26K followers, [--] engagements

"Cancer as a Chronic Disease: The Past the Present & the Future of #CancerResearch @george_clinical @georgeinstitute https://buff.ly/2v3R0ke https://buff.ly/2v3R0ke"
X Link 2017-08-06T22:00Z 26K followers, [--] engagements

"How Innovations in #Data Visualization Are Accelerating Data Cleaning and Improving Quality @bioclinica https://buff.ly/2wO47Hi https://buff.ly/2wO47Hi"
X Link 2017-09-08T22:00Z 26K followers, [--] engagements

"Your Health Records Don't Belong To You. It's Time You Demand Them https://buff.ly/2iyWLDd https://buff.ly/2iyWLDd"
X Link 2017-12-03T23:00Z 26K followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing